p53, c-erbB, and Ki-67 expression in ovaries removed prophylactically from women with a family history of ovarian cancer

被引:14
|
作者
Werness, BA
Afify, AM
Eltabbakh, GH
Huelsman, K
Piver, MS
Paterson, JM
机构
[1] Roswell Pk Canc Inst, Div Pathol, Buffalo, NY USA
[2] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY USA
[3] Childrens Hosp, Med Ctr, Dept Human Genet, Cincinnati, OH 45229 USA
[4] Buffalo Gen Hosp, Dept Pathol, Buffalo, NY 14203 USA
关键词
ovarian neoplasms; precancerous conditions; p53; c-erbB-2; Ki-67; prophylactic oophorectomy; familial ovarian cancer;
D O I
10.1097/00004347-199910000-00008
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Prophylactically removed ovaries from 64 women were compared with those from 30 women with no known family history of ovarian cancer for expression of the p53 tumor suppressor protein, the c-erbB-2 oncoprotein, and for the proliferation antigen Ki-67. All analyses were performed without knowledge of the family history. Ki-67 was expressed in rare nuclei in both the surface and cyst epithelial cells, whereas p53 was expressed in rare nuclei only in cyst epithelial cells. Neither the proportion of positive cases nor the intensity of staining differed between groups. c-erbB2 was not expressed in surface or cyst epithelium in any case from either group. Nuclei of granulosa and granulosa lutein cells expressed both Ki-67 and p53. In conclusion, increased expression of p53, c-erbB2, and Ki-67 was not found in the epithelium of prophylactically removed ovaries, suggesting that increased expression occurs later in the development of carcinoma or invasive tumor evolves too quickly to identify expression of these proteins in preinvasive epithelium.
引用
收藏
页码:338 / 343
页数:6
相关论文
共 50 条
  • [1] p53, c-erbB2 and Ki-67 expression in ovaries removed prophylactically from women with a family history of ovarian cancer.
    Werness, BA
    Afify, AM
    Eltabbakh, GH
    Piver, MS
    Paterson, JM
    LABORATORY INVESTIGATION, 1999, 79 (01) : 126A - 126A
  • [2] Characteristics of ovaries prophylactically removed from women with a family history of ovarian cancer.
    Afify, AM
    Bielat, KL
    Eltabbakh, GH
    Piver, MS
    Patterson, JM
    Werness, BA
    MODERN PATHOLOGY, 1998, 11 (01) : 100A - 100A
  • [3] Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer
    Werness, BA
    Afify, AM
    Bielat, KL
    Eltabbakh, GH
    Piver, MS
    Paterson, JM
    HUMAN PATHOLOGY, 1999, 30 (02) : 151 - 157
  • [4] The expression of c-erbB-2, EGFP, p53 and Ki-67 in ovarian borderline tumors and carcinomas of the ovary
    Min, Kyueng-Whan
    Park, Moon-Hyang
    KOREAN JOURNAL OF PATHOLOGY, 2007, 41 (05) : 296 - 306
  • [5] Significance of p53 and ki-67 expression in prostate cancer
    Verma, Renuka
    Gupta, Veena
    Singh, Jagjeet
    Verma, Monica
    Gupta, Gopal
    Gupta, Sumiti
    Sen, Rajeev
    Ralli, Megha
    UROLOGY ANNALS, 2015, 7 (04) : 488 - 493
  • [6] Expression of Ki-67 and p53 in meningiomas
    Pavelin, S.
    Becic, K.
    Forempoher, G.
    Mrklic, I.
    Pogorelic, Z.
    Titlic, M.
    Andelinovic, S.
    NEOPLASMA, 2013, 60 (05) : 480 - 485
  • [7] Expression of PCNA, Ki-67, c-erbB-2 and p53 in salivary gland tumours
    Queiroz, LMG
    Araújo, VC
    JOURNAL OF DENTAL RESEARCH, 1999, 78 (05) : 987 - 987
  • [8] The value of Ki-67 and p53 expression in the diagnosis of borderline ovarian tumors
    Temuçin, TK
    Serinsöz, E
    Berker, B
    Kaygusuz, G
    Ensari, A
    Erdogan, N
    JOURNAL OF PATHOLOGY, 2001, 193 : 36A - 36A
  • [9] Expression of P53 and Proliferating Antigen Ki-67 in Breast Cancer
    张艳梅
    付红
    杜金荣
    黑龙江医学, 2001, (10) : 743 - 744
  • [10] Heterogeneity of Ki-67 and p53 expression in glioblastomas
    Jakovlevs, A.
    Strumfa, I.
    Vanags, A.
    Gardovskis, J.
    VIRCHOWS ARCHIV, 2014, 465 : S252 - S253